Concepedia

OA07.08 HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed, Phase II Platform Study in Patients with NSCLC, who Progressed on Anti-PD(L)1 Therapy

Benjamin Besse, Mark M. Awad, Patrick M. Forde, Michael Thomas, K. Park, Geraldine Goss, Naiyer A. Rizvi, Florian Huemer, Maximilian J. Hochmair, Jaafar Bennouna,

Journal of Thoracic Oncology · 2021 · 23 citations · 0 references

DOI

Concepts